Ebixa is also available as an oral solution, which is supplied with a pump that delivers 5 mg memantine hydrochloride with each activation. What is Ebixa used for? Ebixa is used to treat patients with moderate to severe Alzheimer’s disease.

Ebixa: Ebixa, brand name of Memantine, is a NMDA receptor antagonist medication used to treat people with moderate-to-severe Alzheimer's disease

2025年1月7日 · In order to lower the risk of side effects, the dose should be achieved by upward titration with 5 mg per week over 3 weeks, achieving the maintenance dose of 20 mg/day from the start of week 4 according to the following dosage guideline:

为了减少不良反应的发生,在治疗的前3周应按每周递增5mg剂量的方法逐渐达到维持剂量,具体如下: 治疗第一周的剂量为每日5mg ,每日一次, 第二周每日10mg,每日一次, 第三周每日15mg ,每日一次, 第四周开始以后服用推荐的维持剂量每日20mg,每日一次。 老年患者:根据临床研究的结果,65 岁以上患者的推荐剂量为每日20mg,每日一次(参见【老年用药】)。 儿童及青少年患者:由于尚无本品用于儿童及青少年的安全性及有效性数据,不推荐本品用于儿童及青少年(参见【儿童用药】)。 …

2021年12月13日 · Ebixa should be taken orally once daily at the same time each day. The solution can be taken with or without food. The solution must not be poured or pumped into the mouth directly from the bottle or the pump, but should be dosed onto a spoon or into a glass of water using the pump.

Ebixa is a medicine that contains the active substance memantine hydrochloride. It is available as tablets (5 mg, 10 mg, 15 mg and 20 mg). Ebixa is also available as an oral solution, which is supplied with a pump that delivers 5 mg memantine hydrochloride with each activation.

2025年1月18日 · Memantine helps to ease the symptoms of dementia in Alzheimer's disease. Take one dose every day, at the same time of day each day. You can take memantine either before or after meals. You will be given a small dose when you first start treatment. This will gradually be increased over the following few weeks. Can memantine cause problems?

2016年7月8日 · Ebixa® belongs to a group of medicines called NMDA-receptor antagonists. The action of Ebixa® on NMDA-receptors may help normalize the transmission of nerve signals, which may help slow the decline in some of the symptoms of Alzheimer disease. When it should not be used: • You should not be taking Ebixa® if you are pregnant, unless

2016年7月8日 · Ebixa , treatment was initiated at 5 mg/day and increased weekly by 5 mg/day to a dose of 20 mg/day (10 mg twice a day). Study Outcome Measures: In each study, the efficacy of Ebixa

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.